Revvity Signals - Drug Discovery

News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

EQT Life Sciences Co-Leads EUR 51 Million Series B Funding for Exciva to Advance Alzheimer's Therapy into Phase 2 Clinical Trials

Tuesday, January 20, 2026

EQT Life Sciences coleads a EUR million Series B investment in Exciva to propel its Alzheimers disease therapy into Phase clinical development

Hoth Therapeutics Achieves Key EU Regulatory Milestone Advancing HT-001 Oncology Trial Across Multiple European Countries

Friday, January 16, 2026

Hoth Therapeutics has received a positive regulatory conclusion under the EU Clinical Trials Information System for its HT program paving the way for multicountry site activation in Hungary Spain and Poland

EU Unveils Sweeping Pharma, Biotech, and Medical Device Reforms

Thursday, January 15, 2026

The EU has announced comprehensive reforms to streamline approvals reduce bureaucracy and boost innovation in the pharma biotech and medical device sectors

Kye Pharmaceuticals signs licensing and distribution agreement with Neurim for SLENYTO® in Canada

Wednesday, January 14, 2026

Kye Pharmaceuticals a Canadian specialty pharmaceutical company has entered into a licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO extendedrelease melatonin in Canada

FDA Accepts New Drug Application for Pimicotinib in Tenosynovial Giant Cell Tumour

Tuesday, January 13, 2026

Merck has announced that the US Food and Drug Administration FDA has accepted its new drug application for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumour TGCT

TetraScience Collaborates with Thermo Fisher Scientific to Advance Scientific Data and AI in Laboratories

Tuesday, January 13, 2026

TetraScience has announced a collaboration with Thermo Fisher Scientific aimed at accelerating the use of artificial intelligence across biopharmaceutical research development and manufacturing

Insmed Plans BRINSUPRI Launch in European Union in First Half of 2026 Following Regulatory Progress

Monday, January 12, 2026

Insmed Incorporated announced plans to launch its inhaled treprostinil therapy BRINSUPRI in the European Union during the first half of marking a key expansion in rare disease treatments

ENYO Pharma reports positive Phase 2 data for vonafexor in Alport syndrome and prepares pivotal Phase 3 programme

Friday, January 09, 2026

Lyonbased ENYO Pharma has announced positive Phase Alpestria data for vonafexor in Alport syndrome and is now preparing a pivotal Phase programme and broader renal pipeline strategy

Lilly to Acquire Ventyx Biosciences to Strengthen Oral Treatments for Inflammatory Diseases

Thursday, January 08, 2026

Eli Lilly and Company has entered into a definitive agreement to acquire Ventyx Biosciences a clinicalstage biopharmaceutical company based in San Diego The acquisition aims to expand Lillys

ViCentra Secures Additional $13 Million to Expand European Manufacturing and Commercial Footprint for Kaleido Insulin Patch Pump

Thursday, January 08, 2026

ViCentra has expanded its Series D financing to million with an additional million to scale manufacturing and commercial operations for its Kaleido insulin patch pump across key European markets